(1999). A: Immunological modulation of human cardiac mast cells. Neurochem Res
(1999). Atherosclerosis–an inflammatory disease.
(2008). C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl Lek Listy
(2000). Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation
(1997). Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.
(2004). DE: Critical role of mast cells in inflammatory diseases and the effect of acute stress.
(2002). Endogenous heparin - a protective marker in patient with myocardial infartion. Coron Artery Dis
(1995). Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation
(2005). Inflammation, atherosclerosis, and coronary artery disease.
(2008). Kalogeromitros D: Impact of stress and mast cells on brain metastases.
(2004). Kovanen PT: Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol
(2006). Mast cell biology in evolution.
(2004). Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol
(1999). Morphometrical and stereological analysis of myocardial mast cells in myocarditis and dilated cardiomyopathy. Folia Biol (Praha)
(2007). Peterlin B: Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes. Cardiology
(2009). Petrovic D: Polymorphisms in the promoter region of the basic fibroblast growth factor gene are not associated with myocardial infarction in a Slovene population with type 2 diabetes.
(2007). RL: Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense.
(2008). Saraga-Babic M: Developmental patterns of caspase-3, bax and bcl-2 proteins expression in the human spinal ganglia. J Mol Histol
(2008). SJ: New developments in mast cell biology. Nat Immunol
(2002). SM: Elevated levels of acutephase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes
(2010). St John AL: Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol
(1979). Stereological methods. Practical Methods for Biological Morphometry.
(1997). The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care
(2006). Tse HF: Mast cell contributes to cardiomyocyte apoptosis after coronary microembolization. J Histochem Cytochem
(2007). Zorc-Pleskovic R: The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes. Coll Antropol